CVB Stock Overview
Engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
CurveBeam AI Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.12 |
| 52 Week High | AU$0.41 |
| 52 Week Low | AU$0.09 |
| Beta | 0 |
| 11 Month Change | 25.00% |
| 3 Month Change | -37.84% |
| 1 Year Change | -61.67% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -66.18% |
Recent News & Updates
Shareholder Returns
| CVB | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 15.0% | 1.0% | 0.5% |
| 1Y | -61.7% | 12.2% | 17.4% |
Return vs Industry: CVB underperformed the Australian Medical Equipment industry which returned 12.2% over the past year.
Return vs Market: CVB underperformed the Australian Market which returned 17.4% over the past year.
Price Volatility
| CVB volatility | |
|---|---|
| CVB Average Weekly Movement | 14.7% |
| Medical Equipment Industry Average Movement | 8.7% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in AU Market | 17.0% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: CVB's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: CVB's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 50 | Greg Brown | curvebeamai.com |
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America. The company builds artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions. It is also involved in AI’s Deep Learning AI based platform aids in bone microstructure analysis.
CurveBeam AI Limited Fundamentals Summary
| CVB fundamental statistics | |
|---|---|
| Market cap | AU$44.48m |
| Earnings (TTM) | -AU$23.10m |
| Revenue (TTM) | AU$6.53m |
6.8x
P/S Ratio-1.9x
P/E RatioIs CVB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVB income statement (TTM) | |
|---|---|
| Revenue | AU$6.53m |
| Cost of Revenue | AU$3.52m |
| Gross Profit | AU$3.01m |
| Other Expenses | AU$26.11m |
| Earnings | -AU$23.10m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 46.08% |
| Net Profit Margin | -353.94% |
| Debt/Equity Ratio | 38.8% |
How did CVB perform over the long term?
See historical performance and comparison